MAXCYTE, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Maxcyte, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q2 2020 to Q2 2024.
  • Maxcyte, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $3.56M, a 1.28% increase year-over-year.
  • Maxcyte, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $13.8M, a 4.95% increase year-over-year.
  • Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $14M, a 19% increase from 2022.
  • Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.8M, a 47.7% increase from 2021.
  • Maxcyte, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $7.96M, a 222% increase from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $13.8M $3.56M +$45K +1.28% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-06
Q1 2024 $13.7M $3.02M -$262K -8% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-07
Q4 2023 $14M $3.57M +$456K +14.6% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 $13.5M $3.61M +$410K +12.8% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $13.1M $3.52M +$546K +18.4% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-06
Q1 2023 $12.6M $3.28M +$815K +33.1% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-07
Q4 2022 $11.8M $3.12M +$670K +27.4% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 $11.1M $3.2M +$913K +40% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $10.2M $2.97M +$1.07M +56% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $9.1M $2.46M +$1.14M +86.6% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $7.96M $2.45M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-15
Q3 2021 $2.29M +$1.69M +282% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $1.91M +$1.35M +241% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $1.32M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $598K Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $559K Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-13
* An asterisk sign (*) next to the value indicates that the value is likely invalid.